Keratinocyte growth factor and it's receptor in middle-ear cholesteatoma
Journal Title: Otolaryngologia Polska - Year 2013, Vol 67, Issue 2
Abstract
Aim: Etiology of middle ear cholesteatoma is far from beeing elucidated. Current concepts postulate that cholesteatoma is the result of disturbed wound healing process. Keratinocyte growth factor (KGF) plays important role in wound healing, so it seemed interesting to assess the expression of KGF and its receptor in the cholesteatoma. Material and methods : 25 cholesteatoma and 7 retraction pockets specimens were obtained from the patients during middle ear surgery. The expression of KGF and FGFR2 was evaluated by immunohistochemical staining using polyclonal antibodies. The results were analyzed depending on clinical features such as: localization, number of anatomic sites involved and presence of purulent discharge. Results: KGF expression was detected in the cells of sub epithelial tissue. It was observed in 4/7 (57%) of the specimens of retraction pockets and 11/25 (44%) of cholesteatoma specimens. FGFR2 expression was observed mainly in the cells of spinouts layer of epithelium in 4/7 (57%) specimens of retraction pockets and 19/25 (76%) of specimens of cholesteatoma. Statistically significant (p = 0.011) relationship between the presence of KGF expression in the sub epithelial tissue and the presence of FGFR2 expression in the epithelium was found. There were no differences in the expression of KGF and FGFR2 between retraction pocket and cholesteatoma specimens. Also, no differences in the expression, depending on localization, extend of the cholesteatoma and presence of purulent discharge were observed. Conclusion: KGF and its receptor seem to play an important role in paracrine regulation of cholesteatoma growth.
Authors and Affiliations
Katarzyna Guzińska-Ustymowicz, Agnieszka Kurzyna, Krzysztof Trzpis, Andrzej Kemona, Elżbieta Hassmann-Poznańska
Nasolacrimal duct obstruction after toxic epiderma' necrolysis
SUMMARY Toxic epidermal necrolysis also known as Lyell's syndrome is acute dermatomyositis as an adverse drug reactions. It is characterized by erosions of skin over 30% of total body surface area and is associated with...
Risk factors of tympanoplasties in long-term observation
Objectives: The aim of the study was to evaluate risk factors influencing the results of tympanoplasties on the base of material taken from the Department of Otolaryngology and Laryngological Oncology Collegium Medicum o...
Nowotwory ślinianek: analiza 727 raportów histopatologicznych z jednej instytucji
Wprowadzenie: Guzy ślinianek stanowią 3-10% nowotworów głowy i szyi. Najczęściej zajęta zostaje ślinianka przyuszna (64-80%). Guzy złośliwe rozpoznaje się u 15-32% pacjentów. Najczęstszym nowotworem łagodnym jest gruczol...
Problematyka monitorowania chorych leczonych z powodu nowotworów głowy i szyi
Quality of life patients with sudden sensorineural hearing loss
Aim: The aim of this study was the assessment of the quality of life of patients suffering from SSNHL and treated in the Otolaryngology Ward of Regional Specialized Hospital in Słupsk between 2001 and 2010, who were inte...